[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.197.114. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
February 4, 2004

Exogenous Insulin and Hypoglycemia as Prognostic Factors in Critically Ill Patients

Author Affiliations
 

Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.

JAMA. 2004;291(5):558. doi:10.1001/jama.291.5.559-a

To the Editor: Dr Finney and colleagues1 reported that high blood glucose levels in critically ill patients were associated with worsening of prognosis in a dose-response fashion. However, because the study was not prospectively designed to assess the effects of insulin administration, we question the authors' conclusion that exogenous insulin is positively associated with mortality in the ICU. The patients receiving higher doses of insulin to maintain glucose levels could have been more severely ill and insulin resistant, and this selection bias could have undersestimated any beneficial effects of exogenous insulin. Moreover, patients receiving insulin are not comparable to those who did not receive insulin; they would be expected to have a higher mortality had they not been given insulin, perhaps equivalent to the group in the higher glucose band. We are similarly unconvinced that insulin resistance did not play a significant role, as insulin-resistant patients require higher insulin doses than do insulin-sensitive patients to maintain a particular glucose level, irrespective of the prevailing glucose level.

First Page Preview View Large
First page PDF preview
First page PDF preview
×